Today

Agents

Chat

Arena

Discover

More

App

Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15 - SANA News | Rallies

Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15

SANA•2026-08-10

Quarterly results

Aug. 10 (Reuters) - Sana Biotechnology Q2 operating expenses USD 65.42 million.

Q2 adjusted net income USD -39.722 million vs. IBES estimate USD -40.5 million
Q2 net income USD -63.635 million
Q2 EPS USD -0.22

Related News

Generac Home Power Generation President Kyle Andrew Raabe sells 586 shares worth $125,024.1

GNRC•2026-08-10

Fermi signs 15-year data center lease with TensorWave worth about $6.5 billion

FRMI•2026-08-10

ADM prices USD 1 billion bond offering

•

2026-08-10

LifeVantage CEO, director Terrence Moorehead files initial beneficial ownership statement

LFVN•2026-08-10

Ceribell Q2 FY26 net loss widens 41% to $19.27 million; revenue rises 33% to $28.1 million

CBLL•2026-08-10